Lead Product(s) : Fosamprenavir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : ViiV Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Details : Fosamprenavir is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of HIV Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 18, 2010
Lead Product(s) : Fosamprenavir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : ViiV Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
